Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Amiloride hydrochloride
Drug ID BADD_D00105
Description A pyrazine compound inhibiting sodium reabsorption through sodium channels in renal epithelial cells. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with diuretics to spare potassium loss. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p705)
Indications and Usage For use as adjunctive treatment with thiazide diuretics or other kaliuretic-diuretic agents in congestive heart failure or hypertension.
Marketing Status Prescription
ATC Code C03DB01
DrugBank ID DB00594
KEGG ID D00649
MeSH ID D000584
PubChem ID 16230
TTD Drug ID D0I0RJ
NDC Product Code 17337-0500; 63629-2114; 57721-671; 60429-275; 49884-117; 42794-005
Synonyms Amiloride | Amiduret Trom | Trom, Amiduret | Amiloberag | Midoride | Amiloride Hydrochloride, Anhydrous | Anhydrous Amiloride Hydrochloride | Hydrochloride, Anhydrous Amiloride | Kaluril | Midamor | Modamide | Amidal | Amiloride Hydrochloride | Hydrochloride, Amiloride
Chemical Information
Molecular Formula C6H8ClN7O.ClH
CAS Registry Number 2016-88-8
SMILES C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal haemorrhage24.07.02.009; 07.12.02.001--Not Available
Gastrointestinal pain07.01.05.005--
Gynaecomastia21.05.04.003; 05.05.02.003--
Haemoglobin13.01.05.018--Not Available
Headache17.14.01.001--
Hepatic encephalopathy17.13.01.003; 09.01.03.006--Not Available
Hepatic function abnormal09.01.02.001--Not Available
Hepatocellular injury09.01.07.008--Not Available
Hyperkalaemia14.05.03.001--
Hyperuricaemia14.09.01.003--
Hyponatraemia14.05.04.002--
Insomnia19.02.01.002; 17.15.03.002--
Intraocular pressure increased13.07.04.002--Not Available
Jaundice09.01.01.004; 01.06.04.004; 23.03.03.030--Not Available
Libido decreased21.03.02.005; 19.08.03.001--
Liver disorder09.01.08.001--Not Available
Muscle spasms15.05.03.004--
Muscular weakness17.05.03.005; 15.05.06.001--
Musculoskeletal pain15.03.04.007--
Nasal congestion22.04.04.001--
Nausea07.01.07.001--
Neck pain15.03.04.009--
Nervousness19.06.02.003--Not Available
Neutropenia01.02.03.004--Not Available
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.007--
Orthostatic hypotension17.05.01.020; 24.06.03.004--Not Available
Pain08.01.08.004--
Pain in extremity15.03.04.010--
Palpitations02.01.02.003--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages